187 related articles for article (PubMed ID: 24248418)
1. Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer.
Huang YJ; Frazier ML; Zhang N; Liu Q; Wei C
Dig Dis Sci; 2014 May; 59(5):968-75. PubMed ID: 24248418
[TBL] [Abstract][Full Text] [Related]
2. Reverse phase protein array: a tool for signaling pathway profiling in the era of genome resequencing.
Yamada T
Dig Dis Sci; 2014 May; 59(5):895-6. PubMed ID: 24595655
[No Abstract] [Full Text] [Related]
3. Evaluation of reverse phase protein array (RPPA)-based pathway-activation profiling in 84 non-small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.
Ummanni R; Mannsperger HA; Sonntag J; Oswald M; Sharma AK; König R; Korf U
Biochim Biophys Acta; 2014 May; 1844(5):950-9. PubMed ID: 24361481
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
5. Identification of differentially expressed proteins from primary versus metastatic pancreatic cancer cells using subcellular proteomics.
McKinney KQ; Lee JG; Sindram D; Russo MW; Han DK; Bonkovsky HL; Hwang SI
Cancer Genomics Proteomics; 2012; 9(5):257-63. PubMed ID: 22990105
[TBL] [Abstract][Full Text] [Related]
6. Proteomic modulation in breast tumors after metformin exposure: results from a "window of opportunity" trial.
Kalinsky K; Zheng T; Hibshoosh H; Du X; Mundi P; Yang J; Refice S; Feldman SM; Taback B; Connolly E; Crew KD; Maurer MA; Hershman DL
Clin Transl Oncol; 2017 Feb; 19(2):180-188. PubMed ID: 27305912
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
[TBL] [Abstract][Full Text] [Related]
8. Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics.
Yoneyama T; Ohtsuki S; Honda K; Kobayashi M; Iwasaki M; Uchida Y; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Huang W; Yamada T; Tachikawa M; Terasaki T
PLoS One; 2016; 11(8):e0161009. PubMed ID: 27579675
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer.
Mao Y; Shen J; Lu Y; Lin K; Wang H; Li Y; Chang P; Walker MG; Li D
Oncotarget; 2017 Jun; 8(26):42537-42547. PubMed ID: 28418924
[TBL] [Abstract][Full Text] [Related]
10. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence.
Nanjundan M; Byers LA; Carey MS; Siwak DR; Raso MG; Diao L; Wang J; Coombes KR; Roth JA; Mills GB; Wistuba II; Minna JD; Heymach JV
J Thorac Oncol; 2010 Dec; 5(12):1894-904. PubMed ID: 21124077
[TBL] [Abstract][Full Text] [Related]
11. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry.
Shen J; Person MD; Zhu J; Abbruzzese JL; Li D
Cancer Res; 2004 Dec; 64(24):9018-26. PubMed ID: 15604267
[TBL] [Abstract][Full Text] [Related]
12. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
13. Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas.
Capurso G; Crnogorac-Jurcevic T; Milione M; Panzuto F; Campanini N; Dowen SE; Di Florio A; Sette C; Bordi C; Lemoine NR; Delle Fave G
Neuroendocrinology; 2005; 81(5):311-21. PubMed ID: 16179808
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
15. Target proteomic profiling of frozen pancreatic CD24+ adenocarcinoma tissues by immuno-laser capture microdissection and nano-LC-MS/MS.
Zhu J; Nie S; Wu J; Lubman DM
J Proteome Res; 2013 Jun; 12(6):2791-804. PubMed ID: 23679566
[TBL] [Abstract][Full Text] [Related]
16. Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.
Xu T; Su B; Huang P; Wei W; Deng Y; Sehgal V; Wang D; Jiang J; Zhang G; Li A; Yang H; Claret FX
Proteomics Clin Appl; 2017 May; 11(5-6):. PubMed ID: 27883284
[TBL] [Abstract][Full Text] [Related]
17. Using reverse-phase protein arrays as pharmacodynamic assays for functional proteomics, biomarker discovery, and drug development in cancer.
Lu Y; Ling S; Hegde AM; Byers LA; Coombes K; Mills GB; Akbani R
Semin Oncol; 2016 Aug; 43(4):476-83. PubMed ID: 27663479
[TBL] [Abstract][Full Text] [Related]
18. Detection of pancreatic cancer using antibody microarray-based serum protein profiling.
Ingvarsson J; Wingren C; Carlsson A; Ellmark P; Wahren B; Engström G; Harmenberg U; Krogh M; Peterson C; Borrebaeck CA
Proteomics; 2008 Jun; 8(11):2211-9. PubMed ID: 18528842
[TBL] [Abstract][Full Text] [Related]
19. Reverse phase protein arrays in signaling pathways: a data integration perspective.
Creighton CJ; Huang S
Drug Des Devel Ther; 2015; 9():3519-27. PubMed ID: 26185419
[TBL] [Abstract][Full Text] [Related]
20. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
